The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey


Kilickap S., Olmez O. F. , Cicin I., Demirci U., Alan O., Cabuk D., ...More

43rd ESMO Congress (ESMO), Munich, Germany, 19 - 23 October 2018, vol.29, pp.505 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 29
  • City: Munich
  • Country: Germany
  • Page Numbers: pp.505